1-(2-Hydroxyethyl)piperazine → HCID 70001160, compound
Reaction equation
[OH:1][CH2:2][CH2:3][N:4]1[CH2:9][CH2:8][NH:7][CH2:6][CH2:5]1.[C:10]1([S:16]([C:19]2[C:20]([S:30][CH3:31])=[N:21][N:22]3[C:27](Cl)=[CH:26][C:25]([CH3:29])=[N:24][C:23]=23)(=[O:18])=[O:17])[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1>>[C:10]1([S:16]([C:19]2[C:20]([S:30][CH3:31])=[N:21][N:22]3[C:27]([N:7]4[CH2:8][CH2:9][N:4]([CH2:3][CH2:2][OH:1])[CH2:5][CH2:6]4)=[CH:26][C:25]([CH3:29])=[N:24][C:23]=23)(=[O:18])=[O:17])[CH:11]=[CH:12][CH:13]=[CH:14][CH:15]=1Participants
3
Procedure
0.26 g (2 mmol) of 1(2-hydroxyethyl)-piperazine was added to a solution of 0.35 g (1 mmol) of 3-benzenesulphonyl-7-chloro-5-methyl-2-methylsulphanyl-pyrazolo[1,5 a]pyrimidine and stirred at 60° for 2 hrs. The reaction solution was cooled to RT and evaporated in a high vacuum. The residue was partitioned between 2N NaOH and CH2Cl2. The aqueous phase was extracted three times with CH2Cl2, and he combined organic phases were dried (MgSO4), filtered and evaporated. Subsequent chromatography (SiO2,CH2Cl2/MeOH 19:1) and crystallization from EtOH yielded 0.36 g (73%) of 2-[4(3-benzenesulphonyl-5-methyl-methylsulphanyl-pyrazolo[1,5-a]pyrimidin-7-yl) -piperazin-yl]-ethanol as colorless crystals, m.p. 189-190°.
Workup
- customevaporated in a high vacuum
- customThe residue was partitioned between 2N NaOH and CH2Cl2
- extractionThe aqueous phase was extracted three times with CH2Cl2, and he
- dry with materialwere dried (MgSO4)
- filtrationfiltered
- customevaporated
- customSubsequent chromatography (SiO2,CH2Cl2/MeOH 19:1) and crystallization from EtOH
Sources & evidence
- ORD record
- ord-936c09be4351469a9a1dc2c4e6b98a05
- Source dataset
- uspto-grants-2001_02
- Patent number
- US06194410B1
Reaction notes
Loading…